A novel recombinant Hepatitis D virus-like particle vaccine elicits human MHC calss 1 restricted CTL responses, which protect against establishment and growth of tumours expressing the E7 oncoprotein (1998–1999)
- Abstract:
- A novel recombinant Hepatitis D virus-like particle vaccine elicits human MHC calss 1 restricted CTL responses, which protect against establishment and growth of tumours expressing the E7 oncoprotein associated with cervical cancer
- Grant type:
- Queensland Cancer Fund
- Researchers:
-
-
Emeritus Professor
School of Chemistry and Molecular BiosciencesFaculty of Science
-
- Funded by:
- Queensland Cancer Fund
